Evonik drives sustainable biosurfactant revolution with inauguration of new facility in Slovenská Ľupča, Slovakia
Essen, Germany. Evonik has officially inaugurated its new sustainable biosurfactant plant together with key customers in Slovakia. The triple-digit million-euro facility is the first worldwide to manufacture industrial-scale quantities of rhamnolipid biosurfactants. These exceptionally high-quality, sustainable biosurfactants are already transforming the cleaning, beauty and personal care industries and have huge potential in many other applications.
“We go beyond to create entirely new solutions and drive the sustainable transformation across multiple industries. Our leadership, based on systems thinking and a shared vision with our customers, has made this scalable action possible,” said Christian Kullmann, CEO of Evonik.
Evonik has been leading the development of industrial-scale biosurfactants with its IP-protected, fermentation-based process for rhamnolipid production. Rhamnolipids are made from renewable corn feedstocks using a biotechnological process. This yields a high-performing, non-toxic, biodegradable biosurfactant. Rhamnolipids are increasingly in demand because they provide a sustainable alternative to surfactants based on fossil sources or tropical oils.
By 2030, Evonik aims to have invested more than €3 billion in Next Generation Solutions – products with superior sustainability benefits. One example is the biosurfactant technology platform that Evonik is building to serve diverse industries.
Evonik’s expertise in biotechnology is spearheaded by its life sciences division, Nutrition & Care. Driven by sustainability, the division is using innovative biosolutions to address the challenges of biocircular care through closed-loop carbon systems, while maintaining high functionality and preserving biodiversity. In addition to biosurfactants, Nutrition & Care’s biosolutions include biotech actives, cell culture solutions and nucleic acid-based medicines.
The new facility is based at Evonik Fermas, the company’s site in Slovenská Ľupča, Slovakia. Biotechnology capabilities at the site have been built up over many decades, making it the logical choice for the first industrial-scale rhamnolipid production facility. This reinforces the position of Evonik Fermas as a biotechnology scale-up and launch platform for Evonik.
Categories
Countries
Companies
Latest news
MSSA doubles production capacity for sodium methylate in La Rochelle, France
The strategic investment will double MSSA's annual production capacity for sodium methylate from 20,000 tonnes to 40,000 tonnes, reinforcing the company's commitment to meeting the growing demand f...
Dreexo Energy to Launch Circular Economy Plant in Cádiz, Advancing Sustainable Industry in Andalucía
Construction of a new facility in the Cádiz Free Trade Zone. The project is expected to break ground in early 2026 and be operational by year’s end.
BASF invests in new semiconductor-grade sulfuric acid plant in Ludwigshafen, Germany
BASF SE, Ludwigshafen →Essential ultra-pure chemical enabling advanced semiconductor manufacturing processes New capacity meets growing demand for the manufacturing of chips in Europe
Vioneo appoints Wood to design world’s first industrial scale fossil-free plastics facility in Antwerp, Belgium
Port Of Antwerp →the renewably powered and energy efficient plant will be the first facility in the world capable of achieving the production of fossil-free plastics using green methanol at an industrial scale.